RadNet

RadNet EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of RadNet (RDNT) as of Nov 17, 2026 is 71.29. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was 26.28 — a change of 171.32% (higher).

EV/EBITDA

71.29

YoY

171.32%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of RadNet is 2025 71.29 . EV/EBITDA (Enterprise Value to EBITDA) of RadNet was 2024 26.28 . It decreases by 171.32% higher compared to the previous year.

The RadNet EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2018
58.23 USD
Jan 1, 2019
43.78 USD
Jan 1, 2020
52.78 USD
Jan 1, 2021
37.07 USD
Jan 1, 2022
41.71 USD
Jan 1, 2023
28.76 USD
Jan 1, 2024
26.28 USD
Jan 1, 2025
71.29 USD
The RadNet EV/EBITDA history
YEAREV/EBITDAYoY
71.29+171.32%
26.28-8.63%
28.76-31.05%
41.71+12.51%
37.07-29.76%
52.78+20.57%
43.78-24.83%
58.23+14.49%
50.87-10.92%
57.10-5.45%
60.39+13.74%
53.10—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RadNet Stock analysis

What does RadNet do? RadNet Inc is a leading company in the field of diagnostic imaging in the United States. The company was founded in 1985 and has since undergone impressive development. Today, RadNet operates the largest network of diagnostic imaging centers in the United States and offers a comprehensive range of diagnostic and therapeutic procedures. RadNet's business model is focused on providing high-quality diagnostic imaging services at competitive prices. The company generates most of its revenue by providing imaging services to Medicare patients and private patients funded by insurers and employers. RadNet also offers its services directly to healthcare facilities, including physician practices, hospitals, and clinics. RadNet offers a wide range of diagnostic imaging services, including X-rays, CT scans, MRI scans, and nuclear medicine procedures. The company also offers specialized imaging services, including mammography, ultrasound, and PET-CT. RadNet, along with its partners, also provides radiation therapy and other cancer treatments. In recent years, RadNet has also experienced strong development in the field of telemedicine and artificial intelligence (AI). An AI-based image processing platform has been developed to assist in the detection of cancer and other diseases. The platform uses innovative algorithms to read and analyze imaging results faster and more accurately. The company has also conducted a series of acquisitions in recent years to strengthen its position in the field of diagnostic imaging. In 2017, the company acquired Doshi Diagnostics Imaging Services, which operated in New York City. In 2018, the company entered into a long-term partnership with Florida-based Diagnostic Centers of America (DCA), and in 2020, the company acquired Elite Imaging of South Florida LLC. These acquisitions have helped RadNet strengthen its presence in core markets and expand its reach into new areas. RadNet has also made a name for itself by developing innovative technology and new models of collaboration. The company has a firm place in the healthcare and research world, working together with respected health systems, academies, and universities to find new ways to diagnose and treat diseases. In summary, RadNet Inc is a leading company in the field of diagnostic imaging. The company offers high-quality and innovative services tailored to the needs of patients, physicians, and healthcare facilities. RadNet remains committed to achieving the best possible outcomes for its customers and further expanding its position in the market. RadNet is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RadNet stock

EV/EBITDA (Enterprise Value to EBITDA) of RadNet is 71.29 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of RadNet changed from 26.28 to 71.29, representing a 171.32% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) RadNet since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s RadNet with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — RadNet

All Key Metrics — RadNet